These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35476975)

  • 21. Negative regulation of interleukin-12 signaling by suppressor of cytokine signaling-1.
    Eyles JL; Metcalf D; Grusby MJ; Hilton DJ; Starr R
    J Biol Chem; 2002 Nov; 277(46):43735-40. PubMed ID: 12221108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppressor of cytokine signaling-1 attenuates the duration of interferon gamma signal transduction in vitro and in vivo.
    Brysha M; Zhang JG; Bertolino P; Corbin JE; Alexander WS; Nicola NA; Hilton DJ; Starr R
    J Biol Chem; 2001 Jun; 276(25):22086-9. PubMed ID: 11306591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-1alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes.
    Amrani A; Verdaguer J; Thiessen S; Bou S; Santamaria P
    J Clin Invest; 2000 Feb; 105(4):459-68. PubMed ID: 10683375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amplifying IFN-γ Signaling in Dendritic Cells by CD11c-Specific Loss of SOCS1 Increases Innate Immunity to Infection while Decreasing Adaptive Immunity.
    Alice AF; Kramer G; Bambina S; Baird JR; Bahjat KS; Gough MJ; Crittenden MR
    J Immunol; 2018 Jan; 200(1):177-185. PubMed ID: 29150567
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The comparative roles of suppressor of cytokine signaling-1 and -3 in the inhibition and desensitization of cytokine signaling.
    Wormald S; Zhang JG; Krebs DL; Mielke LA; Silver J; Alexander WS; Speed TP; Nicola NA; Hilton DJ
    J Biol Chem; 2006 Apr; 281(16):11135-43. PubMed ID: 16473883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-1β produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: Implications for the timing of tolerizing immunotherapy.
    Bertin-Maghit S; Pang D; O'Sullivan B; Best S; Duggan E; Paul S; Thomas H; Kay TW; Harrison LC; Steptoe R; Thomas R
    Diabetes; 2011 Jan; 60(1):248-57. PubMed ID: 20980463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new type of CD4+ suppressor T cell completely prevents spontaneous autoimmune diabetes and recurrent diabetes in syngeneic islet-transplanted NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1996 Jun; 9(3):331-9. PubMed ID: 8816968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-bet-mediated differentiation of the activated CD8+ T cell.
    Yeo CJ; Fearon DT
    Eur J Immunol; 2011 Jan; 41(1):60-6. PubMed ID: 21182077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An islet-specific CD8+ T cell hybridoma generated from non-obese diabetic mice recognizes insulin as an autoantigen.
    McInerney MF; Burkey J; Guan L; Flynn JC; Oravecz KI; Janeway CA
    Diabetes Res Clin Pract; 2000 Mar; 47(3):151-68. PubMed ID: 10741564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidental CD8 T cell reactivity against caspase-cleaved apoptotic self-antigens from ubiquitously expressed proteins in islets from prediabetic human leucocyte antigen-A2 transgenic non-obese diabetic mice.
    Coppieters KT; Amirian N; von Herrath MG
    Clin Exp Immunol; 2011 Aug; 165(2):155-62. PubMed ID: 21605113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones. Differential requirement for CD8 T-cells.
    Peterson JD; Haskins K
    Diabetes; 1996 Mar; 45(3):328-36. PubMed ID: 8593938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo.
    Fujimoto M; Tsutsui H; Yumikura-Futatsugi S; Ueda H; Xingshou O; Abe T; Kawase I; Nakanishi K; Kishimoto T; Naka T
    Int Immunol; 2002 Nov; 14(11):1343-50. PubMed ID: 12407025
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppressor of cytokine signaling-1 has IFN-gamma-independent actions in T cell homeostasis.
    Cornish AL; Davey GM; Metcalf D; Purton JF; Corbin JE; Greenhalgh CJ; Darwiche R; Wu L; Nicola NA; Godfrey DI; Heath WR; Hilton DJ; Alexander WS; Starr R
    J Immunol; 2003 Jan; 170(2):878-86. PubMed ID: 12517953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressor of cytokine signaling 1 attenuates IL-15 receptor signaling in CD8+ thymocytes.
    Ilangumaran S; Ramanathan S; Ning T; La Rose J; Reinhart B; Poussier P; Rottapel R
    Blood; 2003 Dec; 102(12):4115-22. PubMed ID: 12907450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients.
    Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L
    Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absence of significant Th2 response in diabetes-prone non-obese diabetic (NOD) mice.
    Hartemann-Heurtier A; Richard MF; Boitard C
    Clin Exp Immunol; 1999 May; 116(2):225-30. PubMed ID: 10337011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppressor of cytokine signaling-1 regulates the sensitivity of pancreatic beta cells to tumor necrosis factor.
    Chong MM; Thomas HE; Kay TW
    J Biol Chem; 2002 Aug; 277(31):27945-52. PubMed ID: 12032139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8 T cells in innate immune responses: using STAT4-dependent but antigen-independent pathways to gamma interferon during viral infection.
    Suarez-Ramirez JE; Tarrio ML; Kim K; Demers DA; Biron CA
    mBio; 2014 Oct; 5(5):e01978-14. PubMed ID: 25336459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium meta-arsenite prevents the development of autoimmune diabetes in NOD mice.
    Lee YS; Kim D; Lee EK; Kim S; Choi CS; Jun HS
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):254-61. PubMed ID: 25576766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.